A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
Clinical trial NCT02877173 · UNKNOWN
Trial details
- NCT number
- NCT02877173
- Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-07-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.